ANI Pharmaceuticals | ANIP - Lucro Operacional





Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Assertio Holdings USD -3.05M 569K 2024-09
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Heron Therapeutics USD 38K 3.83M 2025-12
Hikma Pharmaceutical USD 348M 161M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.06B 521M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Perrigo USD 84.4M 9M 2025-12
Sun Pharmaceuticals INR 33.67B 49.9M 2025-09
Teva Pharmaceutical Industries USD 487M 581M 2025-12